Discovering Pancreatic Cancer Early

This page aims to provide comprehensive information about pancreatic cancer, the associated risks, and how methods like the Galleri multi-cancer early detection test can help. 

The Galleri® test represents a breakthrough in cancer detection, offering significant advancements in cancer at an earlier stage. Galleri is a early detection test that uses a "fingerprint" to detect cancer single in a simple blood draw.1,2,3

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.

Doctor hcp lander left

The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. The Galleri test should be used in addition to healthcare provider recommended screening tests.

Understanding Pancreatic Cancer

Pancreatic cancer is often diagnosed at an advanced stage due to its subtle and non-specific symptoms. It originates in the tissues of the pancreas, an organ that lies behind the lower part of the stomach.

Risks Associated with Pancreatic Cancer

  • Smoking: Smokers are twice as likely to develop pancreatic cancer compared to non-smokers.

  • Obesity: Excess body weight has been linked to an increased risk.

  • Genetic Predispositions: Family history and inherited gene mutations such as BRCA1, BRCA2, and others.

  • Ethnicity: African Americans and Ashkenazi Jews have higher incidences.

  • Diabetes: Long-standing diabetes can also be a contributing factor.

Multi-Cancer Blood Tests vs. Single Cancer Tests

Traditional single cancer tests focus on detecting one type of cancer at a time. While they are recommended, they may miss other cancers that could be present in the body. This is where multi-cancer blood tests, like the Galleri test, offer a significant advantage.

  1. Broad Detection Range:  Multi-cancer blood tests screen for multiple types of cancer simultaneously, increasing the chances of early detection of various cancers.
  2. Early Detection: They can detect cancer signals before symptoms develop, which is crucial for cancers like pancreatic cancer where early symptoms are rare and non-specific.
  3. Improved Outcomes: Early detection through multi-cancer tests can lead to earlier treatment, which is often less invasive and more successful.


Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood.

blue bar graph illustrating multi cancer early detection testing nearly doubled the number of cancers detected with recommened screening

Why Choose Galleri?

The Galleri test stands out because it uses advanced technology to detect cancer signals in the bloodstream. It targets certain patterns associated with cancer. This method is not only highly sensitive but also specific, reducing the chances of unnecessary anxiety. 2*

In a world where early detection is key, the Galleri test represents a significant advancement in cancer screening, providing hope for a better outcome. 

blue circle with black text indicating 99.5% in the center
The Galleri test's low risk of false positives minimizes unnecessary diagnostic testing and patient anxiety with 99.5% specificity.
89percent
In participants with cancer, when the Galleri test detected cancer, its prediction of cancer signal origin was correct 89% of the time.

Curabitur malesuada, nibh sed tristique vehicula, ipsum elit consectetur sem, eu elementum tortor ex gravida sapien. Maecenas ultricies lacinia erat et iaculis. Donec ornare ipsum in quam sagittis cursus. Suspendisse tincidunt ex sed urna gravida consectetur. Aenean at semper libero.

  1. US Preventive Services Task Force. A,B,C grade recommendations, cancer, screenings. [cited 2023 Oct 23]. https://www.uspreventiveservicestaskforce.org/uspstf/topic_search_results
  2. American Cancer Society. Cancer facts & figures 2022. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html [GRAIL, LLC. Data on file: GA-2021-0065]
  3. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021 Sep;32(9):1167-77. doi: 10.1016/j.annonc.2021.05.806